Covidien & covid-19: The Tipline for 31 March 2020
As the US faces a shortage of ventilators amidst the covid-19 pandemic, a New York Times report has spotlighted Covidien’s 2012 acquisition of an innovative competitor. The US government had reportedly contracted Newport Medical Instruments to manufacture tens-of-thousands of ventilators for its emergency stockpiles, but those plans collapsed following its acquisition by Covidien, leaving some competition practitioners to question if the Federal Trade Commission missed a “killer acquisition”.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10